Display options
Cite
Siirala W, Saaresranta T, Vuori A, et al. Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study. BMC Palliat Care. 2012;11:26doi: 10.1186/1472-684X-11-26.
Siirala, W., Saaresranta, T., Vuori, A., Salanterä, S., Olkkola, K. T., & Aantaa, R. (2012). Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study. BMC palliative care, 1126. https://doi.org/10.1186/1472-684X-11-26
Siirala, Waltteri, et al. "Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study." BMC palliative care vol. 11 (2012): 26. doi: https://doi.org/10.1186/1472-684X-11-26
Siirala W, Saaresranta T, Vuori A, Salanterä S, Olkkola KT, Aantaa R. Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study. BMC Palliat Care. 2012 Dec 27;11:26. doi: 10.1186/1472-684X-11-26. PMID: 23270406; PMCID: PMC3544688.
Copy Download .nbib Format: NLM
Share it on

BMC Palliat Care. 2012 Dec 27;11:26. doi: 10.1186/1472-684X-11-26.

Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study.

BMC palliative care

Waltteri Siirala, Tarja Saaresranta, Arno Vuori, Sanna Salanterä, Klaus T Olkkola, Riku Aantaa

Affiliations

  1. Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University Hospital and University of Turku, Turku, Finland. [email protected].

PMID: 23270406 PMCID: PMC3544688 DOI: 10.1186/1472-684X-11-26

Abstract

BACKGROUND: Hypoventilation due to respiratory insufficiency is the most common cause of death in amyotrophic lateral sclerosis (ALS) and non-invasive ventilation (NIV) can be used as a palliative treatment. The current guidelines recommend performing spirometry, and recording nocturnal oxyhemoglobin saturation and arterial blood gas analysis to assess the severity of the hypoventilation. We examined whether the respiratory rate and thoracic movement were reliable preliminary clinical signs in the development of respiratory insufficiency in patients with ALS.

METHODS: We measured the respiratory rate and thoracic movement, performed respiratory function tests and blood gas analysis, and recorded subjective hypoventilation symptoms in 42 ALS patients over a 7-year period. We recommended NIV if the patient presented with hypoventilation matching the current guidelines. We divided patients retrospectively into two groups: those to whom NIV was recommended within 6 months of the diagnosis (Group 1) and those to whom NIV was recommended 6 months after the diagnosis (Group 2). We used the Mann Whitney U test for comparisons between the two groups.

RESULTS: The mean partial pressure of arterial carbon dioxide in the morning in Group 1 was 6.3 (95% confidence interval 5.6-6.9) kPa and in Group 2 5.3 (5.0-5.6) kPa (p = 0.007). The mean respiratory rate at the time of diagnosis in Group 1 was 21 (18-24) breaths per minute and 16 (14-18) breaths per minute in Group 2 (p = 0.005). The mean thoracic movement was 2.9 (2.2-3.6) cm in Group 1 and 4.0 (3.4-4.8) cm in Group 2 (p = 0.01). We observed no other differences between the groups.

CONCLUSIONS: Patients who received NIV within six months of the diagnosis of ALS had higher respiratory rates and smaller thoracic movement compared with patients who received NIV later. Further studies with larger numbers of patients are needed to establish if these measurements can be used as a marker of hypoventilation in ALS.

References

  1. Ann Intern Med. 1988 Feb;108(2):217-20 - PubMed
  2. Ann Neurol. 1999 Dec;46(6):887-93 - PubMed
  3. Scand J Clin Lab Invest Suppl. 1982;159:5-20 - PubMed
  4. Neurology. 2009 Oct 13;73(15):1218-26 - PubMed
  5. J Neurol Sci. 1997 Oct;152 Suppl 1:S10-7 - PubMed
  6. Lancet Neurol. 2007 Oct;6(10):913-25 - PubMed
  7. J Neurol Sci. 2011 Jul 15;306(1-2):76-81 - PubMed
  8. Neurol Clin. 1996 May;14(2):399-420 - PubMed
  9. Neurology. 2003 Jul 22;61(2):171-7 - PubMed
  10. Ann Neurol. 1985 Sep;18(3):271-80 - PubMed
  11. J Neurol Sci. 2006 Dec 1;250(1-2):45-9 - PubMed
  12. Ann Neurol. 1985 Oct;18(4):419-31 - PubMed
  13. J Neurol Sci. 1994 Jul;124 Suppl:96-107 - PubMed
  14. Chest. 1993 Feb;103(2):508-13 - PubMed
  15. J Appl Physiol (1985). 1985 Oct;59(4):1152-8 - PubMed
  16. Neurology. 2003 Mar 11;60(5):813-9 - PubMed
  17. Expert Opin Investig Drugs. 2012 Mar;21(3):297-320 - PubMed
  18. N Engl J Med. 2001 May 31;344(22):1688-700 - PubMed
  19. Eur J Neurol. 2012 Mar;19(3):360-75 - PubMed
  20. N Engl J Med. 1994 Mar 3;330(9):585-91 - PubMed
  21. Lancet Neurol. 2006 Feb;5(2):140-7 - PubMed
  22. Respir Care. 2009 Jan;54(1):102-15 - PubMed
  23. Amyotroph Lateral Scler. 2007 Jun;8(3):185-8 - PubMed
  24. Chest. 2006 May;129(5):1322-9 - PubMed

Publication Types